At a time when the number of new drugs in the world's development pipeline has dwindled, the British company e-Therapeutics has formed a partnership with Brazilian company Grupo TCI to establish a joint research facility close to the Amazonian and Atlantic rain forests, to start testing substances from the millions of plants in the most diverse ecosystem on the planet.
New medicines are needed to combat a range of diseases which threaten to reach pandemic levels, including drug-resistant strains of tuberculosis and virus infections like avian flu. New drugs are also being sought for tropical diseases which occur in Brazil, such as hepatitis C, Chagas disease and Leishmaniasis.
In a separate deal, e-Therapeutics is joining forces with CURA, a pharmaceutical consortium backed by the Brazilian Government, which is establishing a cluster of drug discovery, development and marketing industries in North East Brazil. This will give e-Therapeutics a base from which to access to Brazilian pharmaceutical companies.
e-Therapeutics was spun out of Newcastle University in 2003 by Professor Malcolm Young, who developed new 'systems biology' techniques which can accurately predict the biological effect of any substance on any human tissue and on pathogens, such as bacteria and viruses. He attracted more than £10m research funding from the Engineering and Physical Sciences Research Council and other organisations to turn his ideas into practice.Professor Young demonstrated the effectiveness of its technology by correctly predicting the effects of known drugs, such as 103 known antibiotics. But it also uncovered unknown antibiotics, which are now entering drug development.
e-Therapeutics is not alone in hunting for rain forest medicines but has the advantage of a system which typically takes only two weeks to assess a substance, as opposed to two years by conventional processes.
Professor Young, who is now Pro-Vice-Chancellor at Newcastle University, said: 'This is a fantastic opportunity to investigate Brazil's colossal biodiversity with our cutting edge technology. There is enormous potential for drug discovery in the rain forests, where there are millions of plant species, many of which produce bioactive chemicals.'
Roberto Marinho Filho, President of Grupo TCI, said: 'This new partnership will enable us to access our rich resource of natural compounds and, through e-Therapeutics novel technology, determine the medical use of these natural compounds. This will open the current bottlenecks in developing new drugs. We will be using the world’s fastest compound profiling system, so the process of discovery of medicines, which can reduce the two years required currently for these processes to about two weeks.'
e-Therapeutics was able to link up to the Brazilian companies with the assistance of the North East Process Industry Cluster (NEPIC), an organisation formed by the 200 Pharmaceutical, Biotechnology, Speciality, Commodity and Petrochemical companies based in the North East of England. NEPIC says that it intends to provide industrial connections and support for e-Therapeuitics as it grows. Funding for e-Therapeutics has included a £90,000 investment from NStar, an independent early stage technology venturing company, via its Proof of Concept Fund (POC) in 2004. This helped to accelerate the development of e-Therapeutics by financing research and demonstrating the company's capabilities in the pharmaceuticals and biotechnology markets.
Professor Malcolm Young | alfa
Modern genetic sequencing tools give clearer picture of how corals are related
17.08.2017 | University of Washington
The irresistible fragrance of dying vinegar flies
16.08.2017 | Max-Planck-Institut für chemische Ökologie
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
17.08.2017 | Physics and Astronomy
17.08.2017 | Earth Sciences
17.08.2017 | Physics and Astronomy